Dear Editor,In patients with early-stage non-small cell lung cancer(NSCLC),the risk of post-surgical recurrence(REC)is 20%–50%,[1]and the risk of developing a second primary lung cancer(2P)is 3–4 times higher than i...Dear Editor,In patients with early-stage non-small cell lung cancer(NSCLC),the risk of post-surgical recurrence(REC)is 20%–50%,[1]and the risk of developing a second primary lung cancer(2P)is 3–4 times higher than in the general population[2].Distinguishing between REC and 2P can be challenging,complicating treatment of these so called“equivocal”(EQU)cases.展开更多
基金supported by the National Cancer Institute(Grants No.R01-80127,Yang and R01-84354,P.Y.)the National Institutes of Health(Grant No.LM-R01-13438,L.L.,J.W.,and P.Y.).
文摘Dear Editor,In patients with early-stage non-small cell lung cancer(NSCLC),the risk of post-surgical recurrence(REC)is 20%–50%,[1]and the risk of developing a second primary lung cancer(2P)is 3–4 times higher than in the general population[2].Distinguishing between REC and 2P can be challenging,complicating treatment of these so called“equivocal”(EQU)cases.
